The quinoxaline-di-N-oxides carbadox, olaquindox, and quindoxin, which are potent antibacterial agents, were tested for mutagenicity in the Salmonella microsomal system. They all induced base pair substitutions and frameshift mutations in Salmonella, and occurred independently of the presence of a rat liver microsomal fraction in the test system. Mutagenicity was dependent on the presence of their N-oxide groups, since quinoxaline, a completely reduced derivative of quindoxin, was not mutagenic, whereas the partially reduced quinoxaline-N-oxide exhibited a lower mutagenic activity than quindoxin. recA and uvrB Salmonella were found to be more susceptible to mutagenic quinoxaline derivatives than wild-type strains. The mutagenicity of quinoxaline-di-N-oxides was enhanced under anaerobic incubation as was the antibacterial activity. These results suggest that both the antibacterial and mutagenic activity of quinoxalinedi-N-oxides depend upon the same bacterial activation mechanism.
Quinoxaline-di-N-oxides (QdNO's) are known as potent antibacterial agents which act on several gram-positive and -negative species (6, 7, 12) . For this reason they have been used as growth promoters in agricultural stock farming (11, 13, 15) . Two QdNO derivatives, carbadox and olaquindox, are currently added to pig and cattle feeds in several countries. A third substance, quindoxin, was withdrawn from commercial use several years ago.
The antibacterial effect of QdNO's has been the subject of various publications. The results indicate that QdNO's act as inhibitors of deoxyribonucleic acid (DNA) synthesis which subsequently results in DNA breakdown in bacteria (10, 24) . Suter et al. (24) have investigated the mode of action of some QdNO's in more detail. They demonstrated that a bacterial enzyme, QdNO reductase, is needed for the activation of these compounds. Escherichia coli mutants deficient in the function of this enzyme exhibit a 30-fold-higher resistance to QdNO's than the isogenic wild-type strain. Furthermore, it is known that the bactericidal activity of QdNO action is drastically increased under anaerobic growth conditions since the presence of oxygen suppresses activation of these compounds (24 is needed for their activation as DNA attacking agents. Two metabolites of bacterial quindoxin reduction, quinoxaline-N-oxide (QNO) and quinoxaline, have been identified that do not show any antibacterial activity (24) . According to Suter et al. (24) , an unstable radical is the active intermediate in the reduction of N-oxide groups. Electron spin resonance experiments demonstrated the formation of free radicals during QdNO reduction.
Recently, carbadox (21, 26) , olaquindox, and quindoxin (26) were shown to be mutagenic in bacterial and yeast screening systems. The mutagenicity of these compounds was detected in the absence of an exogeneous mammalian enzyme activation system which is usually needed to activate a large number of indirect mutagens (2) . (4) . TA1537 and TA1538 were used for the detection of frameshift mutagens, and TA1535 served for the identification of base pair substitutions. The derivatives of TA1538 and TA1535, i.e., TA98 and TA100, carry the "repair plasmid" pKM101, an R46 derivative which increases the susceptibility of its host to a number of mutagens (18) . All TA tester strains used in this work carry a uvrB deletion and are deep rough (rfa). TA1978 is a uvr' derivative of TA1538. The strains NK875 (recA) and NK995 (rec+) which were used in the repair test were kindly provided by N. Kleckner (Harvard University, Cambridge, Mass.). Chemicals. Carbadox (Fortigro, Mecadox; Pfizer) and olaquindox (Bayo-N-ox; Bayer) were obtained from the manufacturers. Quindoxin (Grofas; Imperial Chemical Industries) was generously provided by W. Suter (Sandoz Ltd., Basel, Switzerland). QNO was from Ferak (Berlin, Federal Republic of Germany), and quinoxaline was from Aldrich. All quinoxaline derivatives were stored in the dark and protected from daylight to avoid photoactivation. The known mutagens which were used as routine controls in the mutagenicity tests were: 9-aminoacridine hydrochloride (Merck-Schuchard), 2-aminofluorene, methyl methane sulfonate (Aldrich), and 4-nitroquinoline-N-oxide (Fluka) . The substances were dissolved in dimethyl sulfoxide (Merck), except for 9-aminoacridine hydrochloride and low concentrations of olaquindox (0.1%), which were dissolved in double-distilled water.
Mutagenicity test. The Salmonella microsomal assay which was developed and extensively described by Ames et al. (4) was used with the following modifications: bacterial stock cultures were prepared by dilution of an overnight culture grown in L broth (16) with an equal amount of 87% sterile glycerol. These cultures were kept at -80°C and were stable for at least 18 months. Freshly grown late-exponential cells (1 x 109 to 2 x 10i bacteria per ml) were taken for each experiment. Difco media were used for the cultivation of bacteria.
The minimal plates for the mutagenicity test were poured as a 1:1 dilution of medium 56 (19) , supplemented with glucose (0.2%) and thiamine (0.2 Ag/ml), with 4% agar. The top agar (0.8% agar) was prepared as described (4) and supplemented with the same amounts of glucose and thiamine as the minimal plates.
For experiments with mammalian metabolic activation of the test compound, Aroclor 1254-induced rat liver homogenates (S-9) were obtained as deep frozen stocks from Litton Bionetics and kept at -80°C. The S-9 was supplemented for use with mineral salts, nicotine adenine dinucleotide phosphate, and glucose-6-phosphorate (Merck) as originally described (4) as S-9 mix. For each plate, 0.5 ml of S-9 mix was added to 2.0 ml of molten top agar. If metabolic activation was not required, the S-9 mix was replaced with an equal amount of an adequate mix containing no S-9 fraction. The test compound solutions and the mix were always freshly prepared immediately before the experiment. The activity of the S-9 mix was routinely checked with strain TA98 and 2-aminofluorene since this substance needs activation to become mutagenic.
The spontaneous his' revertant rates and the positive response with known mutagens (4-nitroquinoline-N-oxide for TA98, TA100, and TA1538; methyl methane sulfonate for TA1535; and 9-aminoacridine hydrochloride for TA1537) were routinely controlled. For the determination of mutagenicity, the numbers of revertants per nanomole of substance were compared as described (17) .
Repair test. The repair test was performed as described (3), except that rich media (L broth with 2% agar and L top agar [1%]) were used instead of minimal media. A 10-,ul volume of test substance dissolved in dimethyl sulfoxide was spotted on a sterile filter disk (6-mm diameter) placed in the center of the agar plate. The zones of killing were measured after overnight incubation of the plates at 37°C.
Determination of minimal inhibitory concentration. The minimal inhibitory concentrations for the tested compounds were determined on L-plates containing serial twofold dilutions of the substance by using the method of Suter et al. (24) . About 105 bacteria per plate were taken as inoculum and distributed with a loop.
Anaerobic growth conditions. For anaerobic growth, the plates were incubated in a GasPak 150 system (Becton Dickinson and Co., Cockeysville, Md.).
After 16 h of anaerobic incubation at 37°C, the minimal plates were further incubated until colonies were visible (36 to 48 h later). The minimal plates for comparing anaerobic and anerobic mutagenesis were additionally supplemented with biotin (2.5 pg/ml).
This modification was necessary to avoid the diffusion of biotin from the top agar overlayer into the plates during the prolonged incubation period.
RESULTS
Mutagenicity of the QdNO's carbadox, olaquindox, and quindoxin. The Salmonella microsome assay described by Ames and coworkers (1, 4) was used to test for mutagenicity. The results obtained with the two strains carrying the repair plasmid pKM101 are presented in Fig. 2 . All three QdNO's were identified as potent inducers of base pair substitutions (TA100) and frameshift mutations (TA98). A dose-response relationship for the increase of mutation rates was found with all substances tested. At higher doses than indicated in Fig. 2 , bacterial growth on the plates was inhibited.
The induction of mutations occurred in the absence of a rat liver microsomal fraction (S-9 mix) in the test system. Olaquindox and carbadox were equally mutagenic whether S-9 mix was added to the plates or not. The mutagenic activity of quindoxin was slightly enhanced by the addition of S-9 mix.
The results in Fig. 2 indicate that carbadox was the most efficient mutagen of the three tested. However, olaquindox was only 3-fold less mutagenic per nanomole, and quindoxin was 18-fold less active than carbadox. The mutagenic threshold for each substance and the strain TA100 was calculated as the concentration which resulted in doubling the spontaneous revertant rate. This was 5 nmol per plate for carbadox, 12 nmol per plate for olaquindox, and 50 nmol per plate for quindoxin.
In addition to TA98 and TA100, their parental strains TA1538 and TA1535 and the strain TA1537 were used in the mutagenicity screening. TA1537 was found to be as susceptible as TA98 for the detection of frameshift mutations induced by the tested QdNO's, but TA1538 and TA1535 exhibited only a low susceptibility to these compounds (data not shown). The addition of S-9 mix to the plates did not enhance the response with these tester strains. Mutagenicity of the reduced quindoxin metabolites quinoxaline and QNO. The results obtained when quinoxaline was tested with TA98 and TA100 are summarized in Table 1 .
No mutagenic activity of quinoxaline could be detected up to 30.7 ymol per plate. This result was also obtained with strains TA1535, TA1537, and TA1538. Higher concentrations than indicated in Table 1 were too toxic for the bacteria to be tested. Similar results were obtained when the system was supplemented with rat liver S-9 mix. Therefore, quinoxaline did not exhibit any mutagenic activity in the Salmonella system. Figure 3 presents the results of QNO tested with TA98 and TA100. QNO did induce base pair substitutions and frameshift mutations but with lower efficiency than the three QdNO's. From the data shown in Fig. 3 , QNO was found to be 18-fold less mutagenic than quindoxin. The lowest detectable mutagenic dosage for TA100 with QNO was at 1.4,umol per plate. Addition of S-9 mix to the test system led to an increase of induced mutations at higher QNO concentrations. This effect was not further investigated.
The mutagenicity of QNO could also be detected with the strains TA1537, TA1535, and TA1538. TA1537 was as susceptible as TA98 to the induction of frameshift mutations by QNO. The strains TA1535 and TA1538 exhibited a significant response with QNO, but were much less susceptible than their pKM101-carrying derivatives (data not shown). Table 3 . The uvrB mutants exhibited an increased susceptibility to the QdNO's compared to the wild-type strain TA1978. The presence of the plasmid pKM101 in TA98 and TA100 which codes for an "errorprone" repair system (20) diminished the susceptibility of its uvrB host but did not restore the wild-type resistance level.
As previously observed with E. coli, the antibacterial activity of the tested QdNO's was enhanced under anaerobic conditions. When the aerobic minimal inhibitory, concentrations of the QdNO's for TA98 (TA100) were compared, carbadox was found to be 4-fold stronger than olaquindox and 13-fold stronger than quindoxin in its antibacterial activity. These findings paralleled the results obtained in the mutagenicity tests where carbadox was identified as the most efficient mutagen followed by olaquindox and quindoxin. However, under anaerobic incubation, TA98 (TA100) became 30-fold more susceptible to carbadox and quindoxin but only 8-fold more susceptible to olaquindox than under aerobic growth.
To study the influence of oxygen limitation on the mutagenic activity of these QdNO's, anaerobic and aerobic mutagenesis was compared in strain TA100. The results of these tests are summarized in Fig. 4 . Also under anaerobic test conditions, carbadox represented the strongest mutagen among the three QdNO's. Its mutagenic activity was about sevenfold higher compared to the aerobic mutagenicity test. The mutagenic effect of olaquindox, however, was not drastically stimulated (1.3-fold), whereas quindoxin was about 13-fold enhanced in its mutagenic activity than under aerobic conditions. In accordance with the highly increased antibacterial activity of carbadox and quindoxin under oxygen limitation, the toxicity of these compounds in the anaerobic mutagenicity test was markedly increased. Therefore, higher amounts than 3.8 nmol per plate for carbadox and 30.8 nmol per plate for quindoxin could not be tested.
When anaerobic and aerobic conditions were compared, a strong relationship between antibacterial and mutagenic activity of the QdNO's was found. Both activities could not be sepa- Switzerland, 1977 ) that reduction of QNO to quinoxaline is not as efficient as the reduction of QdNO to QNO in bacteria could explain this result. It is also possible that the activated form of QNO is less mutagenic than the activated forn of quindoxin.
The three QdNO's tested in this study exhibited significant differences in their mutagenic potency. Suter et al. (24; Suter, Ph.D. thesis) reported that carbadox is more rapidly reduced by bacteria than olaquindox or quindoxin. This corresponds to the finding presented here that the activity of carbadox in the mutagenicity and miniimal inhibitory concentration assay was higher than that of the other two QdNO's. Therefore the increased efficiency of carbadox compared to olaquindox and quindoxin can be related to a better activation of this compound by bacterial reductases. It is known that oxygen suppresses the activity of QdNO reductase (Suter, Ph.D. thesis). This may explain the intensified activity of the QdNO's under anaerobic conditions. The antibacterial and mutagenic activity of the QdNO's was increased under anaerobic incubation with bacteria. The results presented here suggest that the same bacterial ac-VOL. 20 ,these compounds produced for use in animal nutrition.
FIG. 4 . Mutagenic activity of carbadox (A), olaquindox (B), and quindoxin (C) under aerobic (0) and anaerobic (0) incubation with TA100. All tests were performed without metabolic activation. The numbers of spontaneous his+ revertants have been subtracted as described in Fig. 2. tivation mechanism is responsible for both activities.
For a number of mutagens, deactivation mediated by mammalian liver enzymes has been described (5, 9) . We have shown in this work that simultaneous incubation of bacteria with S-9 mix did not result in deactivation of the tested QdNO's. However, a QdNO reductase-like activity has been detected in rat liver cell extracts (Suter, 
